サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1134986

テストステロン補充療法の世界市場規模調査＆予測、製品別（注射剤、外用剤、その他）、地域別分析、2022-2029年

Global Testosterone Replacement Therapy Market Size study & Forecast, by Product (Injectables, Topicals, Others) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
テストステロン補充療法の世界市場規模調査＆予測、製品別（注射剤、外用剤、その他）、地域別分析、2022-2029年
出版日: 2022年10月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

テストステロン補充療法のテストステロンは、ローション、注射、パッチ、ガム/頬部接着剤、ゲル、またはインプラントなどの形状で流通しています。

テストステロンと呼ばれる重要な男性ホルモンは、精子形成、男性の性形質、および生殖を強化する役割を担っています。高齢者人口の増加、不健康なライフスタイル、疾患負荷の増加により、テストステロン不足の有病率は上昇すると予想され、予測期間中にテストステロン補充療法の市場拡大を加速させるでしょう。予測期間中の市場成長を促進する主な要因は、テストステロン欠乏症の有病率の上昇と老年人口の増加です。

"Prevalence of Testosterone Deficiency in Elderly Male and its Association with Frailty and Mobility at a Tertiary Care Centre"と題されたIndian Journal of Endocrinology and Metabolism誌の2021年12月の記事によると、60歳以上の高齢男性におけるテストステロン不足の有病率が21.67%増加したとのことであります。男性のアンドロゲンレベルは、加齢とともに徐々に低下していきます。テストステロンよりも治療の必要性が、このようなテストステロンの過剰生産によって生まれ、市場の拡大を推進します。予想される時間枠では、新製品のイントロダクションの結果、市場シェアが増加します。例えば、AndroGel 1.62%のABジェネリック医薬品であるTestosterone Gel 1.62% Metered Dose Pump（20.25mg/1.25g pump actuation）は、Xiromed LLCによって2020年8月に開発されました。持続的な低テストステロンまたはテストステロン枯渇に関連する男性疾患の代替治療薬です。しかし、テストステロン補充療法の負の影響と製品承認のための厳しいガイドラインが、市場の拡大を制限することになります。

テストステロン補充療法の世界市場調査において考慮される主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米地域は、製品の発売数の増加や規制機関によるアンドロゲン補充療法に関連する認可のため、予測期間中、世界のテストステロン補充療法市場で支配的な地位を占めると推定されます。例えば、商業開発中の製薬会社であるInnovus Pharmaceuticals, Inc.は、成人男性のテストステロンレベルと生産を維持するために設計されたBH Testosterone Booster錠剤について、2019年2月にカナダ保健省から承認を得ました。さらに、アンドロゲン補充治療の市場は、市場参加者による協定の増加により、予測期間中にアジア太平洋地域で大幅に上昇すると予想されます。例えば、2020年8月、製薬技術企業のアンタレスファーマ株式会社とルナタス世界メディカルサプライズ（以下、ルナタス）は、サウジアラビアとアラブ首長国連邦（UAE）におけるエナント酸テストステロン注射薬「XYOSTED」の販売とマーケティングに関する独占販売契約を締結しました。

本レポートに含まれる主な市場参入企業は以下のとおりです。

  • AbbVie Inc
  • Endo Pharmaceuticals Inc
  • Pfizer, Inc
  • Eli Lilly and Company
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • Ferring Pharmaceuticals
  • Acerus Pharmaceuticals Corporation
  • Mylan N.V
  • Perrigo Company Plc

本調査の目的は、近年の様々なセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

製品別

注射剤

外用剤

その他

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019-2029年
    • テストステロン補充療法市場：地域別、2019年～2029年
    • テストステロン補充療法市場：製品別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 テストステロン補充療法の世界市場定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 テストステロン補充療法の世界市場力学

  • テストステロン補充療法市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • テストステロン欠乏症の有病率の増加
      • 老年人口の増加
    • 市場の課題
      • 厳しい規則と規制
    • 市場機会
      • 主要な市場参加者別イニシアティブの高まり

第4章 世界のテストステロン補充療法市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 テストステロン補充療法の世界市場：製品別

  • 市場スナップショット
  • テストステロン補充療法の世界市場：製品別、性能-ポテンシャル分析
  • テストステロン補充療法の世界市場、製品別推定・予測、2019-2029年
  • テストステロン補充療法市場、サブセグメント分析
    • 注射剤
    • 外用薬
    • その他

第7章 テストステロン補充療法の世界市場：地域別分析

  • テストステロン補充療法市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
    • カナダ
  • 欧州テストステロン補充療法市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域のテストステロン補充療法市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのテストステロン補充療法市場のスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • AbbVie Inc
      • 主な情報
      • 概要
      • 財務（データの入手状況により異なります）
      • 製品概要
      • 最近の開発状況
    • Endo Pharmaceuticals Inc
    • Pfizer, Inc
    • Eli Lilly and Company
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd
    • Ferring Pharmaceuticals
    • Acerus Pharmaceuticals Corporation
    • Mylan N.V
    • Perrigo Company Plc

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Testosterone Replacement Therapy Market, report scope
  • TABLE 2. Global Testosterone Replacement Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Testosterone Replacement Therapy Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Testosterone Replacement Therapy Market
  • TABLE 69. List of primary sources, used in the study of global Testosterone Replacement Therapy Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Testosterone Replacement Therapy Market, research methodology
  • FIG 2. Global Testosterone Replacement Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Testosterone Replacement Therapy Market, key trends 2021
  • FIG 5. Global Testosterone Replacement Therapy Market, growth prospects 2022-2029
  • FIG 6. Global Testosterone Replacement Therapy Market, porters 5 force model
  • FIG 7. Global Testosterone Replacement Therapy Market, pest analysis
  • FIG 8. Global Testosterone Replacement Therapy Market, value chain analysis
  • FIG 9. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Testosterone Replacement Therapy Market, regional snapshot 2019 & 2029
  • FIG 15. North America Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Testosterone Replacement Therapy Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Testosterone Replacement Therapy Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The distribution of testosterone during testosterone replacement treatment may take the form of lotions, injections, patches, gums/buccal adhesives, gels, or implants. A key male hormone called testosterone is in charge of enhancing spermatogenesis, male sexual traits, and reproduction. The prevalence of testosterone insufficiency is anticipated to rise as a result of the growing older population, unhealthy lifestyles, and disease load, which will accelerate the expansion of the market for testosterone replacement therapy over the forecasted period. Major driving factors driving the growth of the market over the forecasted period are growing prevalence of testosterone deficiency and growing number of geriatric populations.

The prevalence of testosterone deficiency in older men over 60 years of age increased by 21.67%, according to a December 2021 article in the Indian Journal of Endocrinology and Metabolism titled "Prevalence of Testosterone Deficiency in Elderly Male and its Association with Frailty and Mobility at a Tertiary Care Centre." Men's androgen levels gradually decline as they age. A need for treatment rather than testosterone is created by such testosterone overproduction, which propels market expansion. In the anticipated timeframe, market share will increase as a result of new product introductions. For instance, the AB generic version of AndroGel 1.62%, Testosterone Gel 1.62% Metered Dose Pump (20.25mg / 1.25g pump actuation), was developed by Xiromed LLC in August 2020. It is an alternate treatment for male diseases linked to persistent low testosterone or testosterone depletion. The negative consequences of testosterone replacement therapy and tight guidelines for product approval, however, will limit market expansion.

The key regions considered for the Global Testosterone Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America region is estimated to hold dominant position in the worldwide testosterone replacement therapy market over the forecast period, owing to rising number of product launches and approvals connected with androgen replacement therapy by regulatory agencies. For instance, Innovus Pharmaceuticals, Inc., a pharmaceutical firm in commercial development, got approval from Health Canada in February 2019 for its BH Testosterone Booster pills, which are designed to maintain testosterone levels and production in adult males. Additionally, the market for androgen replacement treatment is anticipated to rise significantly in Asia Pacific over the course of the projected period due to an increase in agreements by market participants. For instance, in August 2020, the pharmaceutical technology company Antares Pharma, Inc. and Lunatus Global Medical Supplies ('Lunatus') signed an exclusive distribution agreement for the distribution and marketing of XYOSTED, a testosterone enanthate injection, in Saudi Arabia and the United Arab Emirates (UAE).

Major market players included in this report are:

AbbVie Inc

Endo Pharmaceuticals Inc

Pfizer, Inc

Eli Lilly and Company

Bayer AG

Teva Pharmaceutical Industries Ltd

Ferring Pharmaceuticals

Acerus Pharmaceuticals Corporation

Mylan N.V

Perrigo Company Plc

Recent Developments in the Market:

  • KYZATREX was approved by the US Food and Drug Administration for Marius Pharmaceuticals in August 2022. (Testosterone undecanoate). KYZATREX is an oral testosterone replacement therapy ("TRT") that is recommended for adult males with hypogonadism or other diseases linked to a lack of endogenous testosterone.
  • The testosterone undecanoate (TLANDO), an oral treatment for testosterone replacement therapy, was approved by the US Food and Drug Administration (FDA) in March 2022.

Global Testosterone Replacement Therapy Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Injectables

Topicals

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Testosterone Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Testosterone Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Testosterone Replacement Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Testosterone Replacement Therapy Market Dynamics

  • 3.1. Testosterone Replacement Therapy Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of testosterone deficiency
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Strict rules and regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising initiatives by the key market players

Chapter 4. Global Testosterone Replacement Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Testosterone Replacement Therapy Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Testosterone Replacement Therapy Market by Product, Performance - Potential Analysis
  • 6.3. Global Testosterone Replacement Therapy Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
  • 6.4. Testosterone Replacement Therapy Market, Sub Segment Analysis
    • 6.4.1. Injectables
    • 6.4.2. Topicals
    • 6.4.3. Others

Chapter 7. Global Testosterone Replacement Therapy Market, Regional Analysis

  • 7.1. Testosterone Replacement Therapy Market, Regional Market Snapshot
  • 7.2. North America Testosterone Replacement Therapy Market
    • 7.2.1. U.S. Testosterone Replacement Therapy Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Testosterone Replacement Therapy Market
  • 7.3. Europe Testosterone Replacement Therapy Market Snapshot
    • 7.3.1. U.K. Testosterone Replacement Therapy Market
    • 7.3.2. Germany Testosterone Replacement Therapy Market
    • 7.3.3. France Testosterone Replacement Therapy Market
    • 7.3.4. Spain Testosterone Replacement Therapy Market
    • 7.3.5. Italy Testosterone Replacement Therapy Market
    • 7.3.6. Rest of Europe Testosterone Replacement Therapy Market
  • 7.4. Asia-Pacific Testosterone Replacement Therapy Market Snapshot
    • 7.4.1. China Testosterone Replacement Therapy Market
    • 7.4.2. India Testosterone Replacement Therapy Market
    • 7.4.3. Japan Testosterone Replacement Therapy Market
    • 7.4.4. Australia Testosterone Replacement Therapy Market
    • 7.4.5. South Korea Testosterone Replacement Therapy Market
    • 7.4.6. Rest of Asia Pacific Testosterone Replacement Therapy Market
  • 7.5. Latin America Testosterone Replacement Therapy Market Snapshot
    • 7.5.1. Brazil Testosterone Replacement Therapy Market
    • 7.5.2. Mexico Testosterone Replacement Therapy Market
  • 7.6. Rest of The World Testosterone Replacement Therapy Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. AbbVie Inc
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Endo Pharmaceuticals Inc
    • 8.2.3. Pfizer, Inc
    • 8.2.4. Eli Lilly and Company
    • 8.2.5. Bayer AG
    • 8.2.6. Teva Pharmaceutical Industries Ltd
    • 8.2.7. Ferring Pharmaceuticals
    • 8.2.8. Acerus Pharmaceuticals Corporation
    • 8.2.9. Mylan N.V
    • 8.2.10. Perrigo Company Plc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption